| Name | matrix Gla protein |
|---|---|
| Synonyms | GIG36; MGLAP; MGP; Matrix Gla protein; Matrix Gla protein precursor; Matrix gamma carboxyglutamic acid protein; NTI; Matrix Gla proteins… |
| Name | phosphorus |
|---|---|
| CAS | phosphorus |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 19546357 | Zhou YB, Jin SJ, Cai Y, Teng X, Chen L, Tang CS, Qi YF: Lanthanum inhibits vascular calcification induced by plus in rats. Exp Biol Med. 2009 Aug;234(8):908-17. Epub 2009 Jun 22. Lanthanum at 750 mg/kg/day was more effective than 375 mg/kg/day in lessening vascular calcification by significantly reducing plasma phosphorus level, x phosphorus product and ALP activity, by 30.3%, 28.6%, and 68.6%, respectively; reducing aortic phosphorus and contents and ALP activity, by 48%, 53.1%, and 63.5% (all P < 0.01), respectively; reducing aortic mRNA level of OPN and Pit-1, by 55.8% (P < 0.01) and 38.8% (P < 0.05) and protein level of OPN and Pit-1, by 37.2% and 27.2% (both P < 0.01), respectively; and increasing carboxylated matrix Gla-protein (MGP) protein expression by 33.7% (P < 0.05), as compared with rats treated with and alone. |
31(0,1,1,1) | Details |
| 19345526 | Torres PA: [Origin of the mediacalcosis in kidney failure] . J Mal Vasc. 2009 May;34(3):204-10. Epub 2009 Apr 3. It is now possible to identify factors clearly favoring the formation of VC: TNF-alpha (which stimulates cell necrosis/apoptosis), CRP, oxidized lipids, AGEs, leptin, inorganic high -phosphorus product (CaxPO (4)), 1,25-OH (2) D (3) and (3), PTHrP (via an intracrine pathway), cyclic AMP, TGF-beta, bone morphogenic protein 2 (BMP2) and factors protective against the formation of VC: HDL, inorganic albumin, ahsg/fetuin A, osteopontin (OPN), osteoprotegerin (OPG), osteonectin (ON), bone morphogenic protein 7 (BMP7), klotho, PTHrP (via a paracrine pathway), matrix gla protein (MGP), PTH (via Msx2) and |
31(0,1,1,1) | Details |
| 19793187 | Lerner RG, Aronow WS, Sekhri A, Palaniswamy C, Ahn C, Singh T, Sandhu R, McClung JA: use and the risk of valvular calcification. J Thromb Haemost. 2009 Dec;7(12):2023-7. Epub 2009 Sep 28. BACKGROUND: affects the synthesis and function of the matrix Gla-protein, a -dependent protein, which is a potent inhibitor of tissue calcification. Logistic regression analyses were also conducted to investigate whether the relationship stands after adjustment for confounding risk factors such as age, sex, race, ejection fraction, smoking, hypertension, diabetes, dyslipidemia, coronary artery disease (CAD), glomerular filtration rate, phosphorus, -phosphorus product, alkaline phosphatase, use of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins. |
1(0,0,0,1) | Details |
| 19531580 | Ornsrud R, Lock EJ, Glover CN, Flik G: cross-talk with activity in Atlantic salmon (Salmo salar). J Endocrinol. 2009 Sep;202(3):473-82. Epub 2009 Jun 16. VA metabolites, CTR, (Ca), (Mg) and phosphorus (P) were determined in plasma. Expression of bone matrix Gla protein (mgp), collagen 1 alpha2 chain (col1a2) and alkaline phosphatase (alp) mRNA was quantified to reflect osteogenesis. |
1(0,0,0,1) | Details |